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Abstract: The nanotubular surface of titanium implants is known to have superior osteogenic
activity but is also vulnerable to failure because of induced bacterial attachment and consequent
secondary infection. Here, the problem was attempted to be solved by depositing nanosized
tetracycline (TC)-loaded particles in poly(lactic-co-glycolic acid) on titania nanotubes (TNTs)
using the electrospray deposition method. The antibacterial effect of the newly formed TNT
surface was considered using the common pathogen Staphylococcus aureus. Maintenance of the
biocompatibility and osteogenic characteristics of TNTs has been tested through cytotoxicity tests and
osteogenic gene expression/extra-cellular matrix mineralization, respectively. The results showed
that TNTs were successfully formed by anodization, and the characterization of TC deposited on
the TNTs was controlled by varying the spraying parameters such as particle size and coating time.
The TC nanoparticle-coated TNTs showed antibacterial activity against Staphylococcus aureus and
biocompatibility with MC3T3-E1 pre-osteoblasts, while the osteogenic activity of the TNT structure
was preserved, as demonstrated by osteocalcin and osteopontin gene expression, as well as Alizarin
red staining. Hence, this study concluded that the electrosprayed TC coating of TNTs is a simple and
effective method for the formation of bactericidal implants that can maintain osteogenic activity.
Keywords: titanium; titania nanotubes; implants; tetracycline; electrospray deposition; antibacterial;
osteogenic activity
1. Introduction
Successful restoration using bone implants depends on secure bonding between the biomaterial
and bone tissue [1]. The surface properties of a biomaterial are critical factors that play a decisive
role in the success of implant surgery and allow the induction of early adhesion and differentiation of
osteogenic cells to ultimately achieve bone regeneration [2,3].
The oxide film on the surface of titanium (Ti) has excellent biocompatibility [4] and the ability
to integrate with bone by a process known as osseointegration [5]. Thus, it is the most widely used
biomaterial in implants. As a result that the oxide film of a Ti surface is only approximately 100 Å
thick [5], various surface treatments, including resorbable blasted media (RBM), sand-blasted large-grit
acid-etching (SLA) and anodization of titania nanotubes (TNTs), have been developed to thicken the
film and endow it with topographic characteristics that would allow it to have more bone-to-implant
contact [6–8]. Among these surface treatments, anodization of TNTs has the most tuneability to permit
deliberate adjustment of the diameter and length of the tubes [9,10]. Therefore, this treatment possesses
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the potential to induce quick osseointegration and excellent implant fixation at an early phase by
controlling the stem cell fate to adhere, migrate or differentiate [11–13].
Despite these advantages of TNTs, it has also been suggested that such treatment on implants is
vulnerable to failure because of the increased chance of bacterial attachment compared to conventional
machined Ti surfaces [14]. To prevent bacterial infections at the site of the implant, systemic delivery
of antibiotics has been typically prescribed after surgery; however, these drugs are accompanied by
possible antibiotic-associated side effects on other systemic organs [15]. Therefore, the investigation
of antibacterial coatings has been progressing to meet the need for an implant surface with both
satisfactory localized osteogenesis and antibacterial activity.
Tetracycline (TC) is a broad-spectrum antibiotic that inhibits bacterial protein synthesis, periodontitis
and osteomyelitis [16–18]. Biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA) are
regularly used as TC carriers due to improved drug encapsulation, controlled release and reduced
cytotoxicity compared to that of other materials [19]. Many of the currently available antibacterial coating
methods, such as the dipping method, result in excellent long-term release [20] but lose the benefit
of the nanotubular structure as the antibacterial coating covers the TNT surface. To compensate for
this shortcoming, the nanoparticle coating process can be conducted by emulsification-diffusion [21],
solvent-emulsion evaporation [22], magnetron sputtering [23] or electrospray deposition (ESD) [24].
ESD involves spraying a solvent that has been atomized by applying high-voltage electricity to
the substrate. The major advantage of ESD is the precise control of the thin films through adjustment
of the solvent type, deposition rate, spray distance, nozzle diameter, etc. Additionally, compared to
other vapor deposition methods, ESD is conducted in an environment at room temperature and
atmospheric pressure; thus, the fabrication process has the advantage of being uncomplicated and
cost-effective [25–27].
Surface attachment of cells and bacteria occurs simultaneously and competitively [28,29],
therefore this study attempted to produce a surface on which the TNTs are nontoxic to cells but
destroy bacteria. In this in vitro study, we investigate a TNT surface modified by anodization with
time-dependent electrosprayed TC nanoparticles on which adhesion of Staphylococcus aureus (S. aureus)
is prevented while osteogenic activity of MC3T3-E1 is maintained due to TNT topographical effects.
2. Materials and Methods
2.1. TNT Fabrication
Ti discs (1.2 mm in diameter and 1 mm in thickness, 99.99% purity; Hyundai Titanium, Incheon,
Korea) were polished with a 3 µm diamond abrasive paste on a polishing cloth and ultra-sonically
degreased in acetone, ethanol and deionized (DI) water, successively, for 5 min each. TNTs were
fabricated using an electrochemical anodization method at 20 V for 1 h using a platinum plate as
the cathode in an electrolyte that consisted of 0.5 wt.% hydrofluoric acid [10]. After anodization,
the specimens were rinsed with DI water and dried in a vacuum chamber for 1 d. Heat treatment was
performed at 450 ◦C for 3 h in a furnace. All specimens were sterilized by ethylene oxide (EO) gas
before the in vitro tests.
2.2. Drug Loading with ESD
TC (0.1 wt.%; Sigma-Aldrich, St. Louis, MO, USA) and PLGA (0.1 wt.%, 50:50, mol wt.
40,000–75,000; Sigma-Aldrich) were dissolved in dichloromethane (Sigma-Aldrich) and stirred with
an agitator for 12 h. The solution was then centrifuged at 4500 rpm for 15 min, and the supernatant
was extracted. Drug loading was performed using an ESD device (NNC-ESP200R, NanoNC, Seoul,
Korea) at a constant voltage of 25 kV. A disposable syringe was filled with TC-PLGA liquid, and the
flow rate was set to 10 µL/min using an infusion pump (KSD 100, KD Scientific, Holliston, MA, USA).
The distance between the precision nozzle and the TNT substrate was set to 15 cm, and the deposition
time was varied from 2 to 60 min (Figure 1). Simple machined Ti (as supplied by the manufacturer
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before TNT fabrication) and TNT substrate without ESD deposition were used as the controls. All the
control and test groups are summarized in Table 1 with an assigned code for the purpose of this study.
Figure 1. Schematic drawings of the (a) electrochemical anodization and (b) electrospray deposition system.
Table 1. Surface properties of substrates.
MA T0 T2 T4 T8 T30 T60
Surface treatment Machined TNT 1 TNT TNT TNT TNT TNT
ESD 2 time (min) 0 0 2 4 8 30 60
1 TNT: titania nanotube, 2 ESD: electrospray deposition.
2.3. Surface and Particle Characterization
X-ray diffraction (XRD; Ultima IV, Rigaku, Tokyo, Japan) was conducted on the T0 sample before
and after the heat treatment as well as on the MA sample to detect and compare the crystallization
of TNT to simply machined Ti. Transmission electron microscopy (TEM; JEM-2010, JEOL, Tokyo,
Japan) and dynamic light scattering (DLS; ZEN 3690, Malvern Instruments, Malvern, UK) were used
to confirm the shape and diameter of TC particles. The particles for DLS were suspended in water
with electrospray deposition. Field-emission scanning electron microscopy (FE-SEM; JSM-6701F, JEOL,
Tokyo, Japan) was used to analyze the structure of the TNTs as well as the morphology of the deposited
TC particles on the test substrates.
2.4. Antibacterial Assay
S. aureus (American Type Culture Collection (ATCC) 29213, Manassas, VA, USA) was cultured
aerobically in brain heart infusion (BHI; Becton, Dickinson and Company, Franklin Lakes, NJ, USA)
medium. The bacteria were seeded on substrates at an initial density of 1.0 × 107 colony forming units
(CFU)/mL and incubated at 37 ◦C for 24 h.
Antibacterial activity was investigated using the SYTO9 and propidium iodide (PI) LIVE/DEAD
BacLight Bacterial Viability/Cytotoxicity Kit™ (Invitrogen, Carlsbad, CA, USA). The bacteria on the
functionalized substrates were gently washed with phosphate-buffered saline (PBS; Gibco, Carlsbad,
CA, USA) and stained with a mixture of two-color nucleic acid stains for 15 min. SYTO9 stains normal
bacteria fluorescent green according to the condition of the bacterial membrane, while dead bacteria are
stained fluorescent red by PI. Immunofluorescence imaging was performed by confocal laser scanning
microscopy (CLSM; LSM700, Carl-Zeiss, Oberkcochen, Germany).
For the quantification of bacterial attachment, bacteria were cultured for 1 d and rinsed with PBS
followed by placement into a glass vial containing new BHI medium. The samples were ultrasonicated
for 5 min to detach the bacteria on the surface of the specimen. The extracted bacterial suspension was
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diluted 10-fold in series, spread on BHI agar plates and then incubated at 37 ◦C for 1 d. Afterwards,
evaluation of antibacterial activity was performed by counting the number of visible S. aureus CFU.
2.5. Cell Culture
Mouse pre-osteoblasts (MC3T3-E1, subclone 4; ATCC) were cultured in alpha minimum
essential medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and 1%
antibiotics/antimycotics (Invitrogen). The cells were incubated in a humidified atmosphere with 5%
CO2 at 37 ◦C until the experiments were performed, and cells with passages less than 5 were used for
the experiments. The cells were placed on the samples at an initial density of 1.0 × 105 cells/mL.
2.6. Cytotoxicity Assay
Cytotoxicity was assessed with calcein AM and ethidium homodimer-1 (ethD-1) staining
(LIVE/DEAD Viability/Cytotoxicity Kit™, Invitrogen) assays. After culturing cells on each control and
test sample for 1 d, the cells on the substrates were washed in Dulbecco’s phosphate-buffered saline
(DPBS; Invitrogen) and stained with calcein AM for live cells (green) and ethD-1 for dead cells (red).
The images of stained cells were observed using a confocal laser microscope (LSM700, Carl-Zeiss).
2.7. Cell Morphology
To evaluate the morphology of attached cells, the cells were cultured on each control or test
sample for 24 h and then washed with wash buffer (0.05% Tween 20 in PBS), followed by fixation
with 4% paraformaldehyde. Fixed cells were then stained for 1 h with fluorescein isothiocyanate
(FITC)-labeled vinculin (Millipore, Billerica, MA, USA), which indicates focal adhesions (green)
and Tetramethylrhodamine (TRITC)-conjugated phalloidin, which indicates actin filaments (red).
The morphology of the cells was observed using CLSM (LSM700, Carl-Zeiss).
2.8. Osteogenic Gene Expression
The expression levels of the osteogenic markers osteopontin (OPN) and osteocalcin (OCN) were
detected by real-time reverse transcription-polymerase chain reaction (real-time RT-PCR). Briefly, after
21 d of culturing the cells on each control or test sample, RNA from the cells was extracted with TRIzol
(Invitrogen). Total RNA was reverse transcribed to complementary DNA (cDNA) using a high-capacity
RNA-to-cDNA kit (Applied Biosystems, Carlsbad, CA, USA). For DNA amplification, solutions
with specific primers and SYBR green (Applied Biosystems) were added to the respective cDNA
samples. Real-time PCR was then performed using an ABI Prism 7500 machine (Applied Biosystems).
The expression level of each osteogenic gene was normalized against the amount of glyceraldehyde
3-phosphate dehydrogenase. To confirm the findings, immunofluorescence staining was performed
with solutions of anti-OPN antibody (Santa Cruz Biotechnology, Dallas, TX, USA) and anti-OCN
antibody (QED Bioscience, San Diego, CA, USA) in blocking solution (1% BSA in PBS) at 4 ◦C for
1 d. After the cells were rinsed with wash buffer, they were soaked in solution with goat anti-mouse
lgG-FITC (Santa Cruz Biotechnology, Dallas, TX, USA) for 1 h. The stained cells were observed using
CLSM (LSM700, Carl-Zeiss).
2.9. Extracellular Matrix Mineralization
Extracellular matrix mineralization was assessed using Alizarin red S (ARS; Sigma-Aldrich)
staining method. After culturing cells on each control or test sample for 3 weeks, adherent cells
were washed with PBS, fixed with absolute ethanol and stained using 2% ARS solution for 15 min.
Stained samples were then washed with DI water, and red-colored extracellular matrix mineralization
was photographed with an optical microscope. For the colorimetric assay, the specimen was soaked in
cetylpyridinium chloride (CPC; Sigma-Aldrich) solution for 1 h so that the stain on the specimen would
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dissolve. The absorbance of the CPC solution was then measured at 560 nm using a spectrophotometer
(Epoch, BioTek Instruments, Winooski, VT, USA).
2.10. Statistical Analysis
All experiments were repeated in triplicate. Quantitative data were expressed as the mean ±
standard deviation and analyzed with SPSS 20.0 software (SPSS Inc., Chicago, IL, USA). One-way ANOVA
combined with Tukey’s post hoc test was used to determine the level of significance. A value of p < 0.05
was considered to be significant.
3. Results
3.1. Surface Characterization
The XRD spectra were obtained from T0 before and after heat treatment as well as from the MA
groups to characterize their surface crystallinity (Figure 2a). It was noted that the (1 0 1) anatase
diffraction peak was only identified in heat-treated T0 (T0-AH in Figure 2a) [30].
Figure 2. Surface characterization of control and test specimen. (a) XRD spectra of machined
Ti (MA), non-heat-treated T0 (T0-BH) and T0 heat-treated at 450 ◦C (T0-AH), characterization of
electrospray-deposited tetracycline nanoparticles by (b) dynamic light scattering for the nanoparticle size and
(c) transmission electron microscopy for the surface morphology of the nanoparticles (scale bar = 100 nm),
and (d) surface morphology of the specimens assessed by FE-SEM (top view) (scale bar = 200 nm).
The diameter of PLGA-coated TC particles produced by the ESD method was approximately
24.36 nm, as shown in Figure 2b, which was confirmed along with the morphology of the particles
using TEM and DLS (Figure 2c).
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The morphology of the control group and the ESD-sprayed test group was verified by FE-SEM
(Figure 2d). The surface of the MA group made by grinding pure Ti was flat, whereas the surface of T0
prepared by anodization treatment with MA as a substrate presented TNTs with regularly shaped
nanotubes that were 100 nm in diameter. The structure of the tubes was shown to be preserved even
after heat treatment. For the samples deposited with TC particles by ESD with increasing spraying time,
the applied particles were evenly distributed along the tube structures, maintaining the unique TNT
topography until 16 min of deposition (T2, T4, T8 and T16 in Figure 2d). However, it was observed that
the entrances of the TNTs were completely sealed following 30 min of deposition (T30 in Figure 2d),
whereas the tube-like structures were difficult to be seen in the FE-SEM image following 60 min of
deposition (T60 in Figure 2d) due to the TC layer.
3.2. Antibacterial Activity
Figure 3a shows the immunofluorescence following the culture of S. aureus on each specimen.
The number of intact live bacteria, which exhibited a green color, was greater in the T0 group than
in the MA group. However, the number of viable S. aureus decreased with increasing spraying time.
The number of viable bacteria was significantly reduced in groups T2 and T4 compared with both MA
and T0, with an increased number of dead bacteria (red color). Furthermore, no intact bacteria were
observed in groups T8, T16, T30 and T60.
Figure 3. (a) Fluorescence images of live (green) and dead (red) stained S. aureus on specimens following
24 h of incubation (scale bar = 200 µm). (b) Antibacterial activity of specimens versus adherent S. aureus
seeded after 24 h assessed using the CFU count method (different letters indicate significantly different
groups at p < 0.05).
Additionally, residual bacterial proliferation was confirmed with the CFU count method (Figure 3b).
The number of colonies was approximately 240 CFU/mL in MA, whereas the T0 group showed CFU
counts of approximately 320 CFU/mL, which is 33% higher than that in the MA group. However, the CFU
numbers decreased significantly to 101 and 25 in the T2 and T4 groups, respectively, both of which
received antibiotics. No colonies were observed in the T8 group or in any of the other groups with a
longer duration of deposition than that of T8, proving the antimicrobial characteristic of TC.
3.3. Cytotoxicity
As stated above, an overdose of TC may be toxic to cells. Therefore, the cytotoxicity was evaluated,
and the results are shown in Figure 4. The patterns of cell distributions and the viability of cells in groups
T2, T4 and T8 were similar to those in T0 despite the increase in spraying time. However, when the
spraying time reached 16 min (T16), the cells became thinner, and dead cells that were stained red
started to appear (arrows on Figure 4). Furthermore, most cells in the T30 groups had a round shape
with an increasing number of dead cells, while most of the cells in T60 appeared to be circular and dead.
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Figure 4. Fluorescence images for evaluation of the cytotoxicity of the surface by 24 h of cell culture
using live (green) and dead (red, arrows in T16) stained osteoblasts (scale bar = 200 µm).
3.4. Cell Morphology
The morphology of attached cells was observed by confocal laser microscopy to investigate the
effects of surface treatment on the cells (Figure 5). In the T0 group, the cytoskeleton was well developed
relative to the MA group, with extended actin filaments (red) and focal adhesions as shown by vinculin
(green). This morphological shape was relatively unchanged in the T8 group in which the TC particles
were introduced.
Figure 5. Fluorescence images of actin (red) and vinculin (green) in osteoblasts cultured on the
specimens for 24 h (scale bar = 50 µm).
3.5. Gene Eexpression
The gene expression of OCN and OPN, markers of osteogenesis, was assessed by both
immunofluorescence and RT-PCR to determine the bioactivity of the control and test specimens
(Figure 6). The RT-PCR results showed the upregulation of osteogenic differentiation by osteoblast
cells on the nanotubular surface (T0) relative to the flat surface (MA) (Figure 6a). This effect was
maintained even after the application of TC on the surface of the nanotubes using the ESD method (T8).
The result was then confirmed with immunofluorescence, which also showed upregulation of OCN in
T0 relative to the MA group (Figure 6b). Additionally, OPN was significantly more densely expressed
in the former group, exhibiting the same pattern as the cells. There was no significant difference in the
amounts of OCN and OPN expression between the T8 and T0 groups; both groups had relatively high
levels of expression.
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Figure 6. Osteogenic differentiation of osteoblasts on the specimens for 21 d. (a) The expression
levels of osteopontin (OPN) and osteocalcin (OCN) assessed by real-time RT-PCR (*p < 0.05 vs. MA).
(b) Fluorescence images of OCN (upper) and OPN (lower) (scale bar = 100 µm).
3.6. Extracellular Matrix Mineralization
Extracellular matrix mineralization was measured with ARS staining (Figure 7a). The surface
of the MA group showed a weak distribution of crystals, while the T0 group had increased calcium
content, which was evident as reddish-black coloration and wave-shaped crystallization nodules
(arrows in Figure 7a). In addition, the calcium crystallization rate in the T8 group was similar to
that in the T0 group. Quantitative analysis through measurement of the absorbance showed that the
absorbance value was significantly higher by 23% in the T0 group than in the MA group, while there
was no statistically significant difference in absorbance between groups T0 and T8 (Figure 7b).
Figure 7. Extracellular matrix mineralization of osteoblasts on the specimens for 21 d assessed by
Alizarin red S (ARS) staining. (a) Optical images (arrows indicate nodules) and (b) colorimetric
quantitative analysis (*p < 0.05 vs. MA).
4. Discussion
Infection is the main reason for early-stage implant failure due to its interference with the bonding
of the implant surface with bone tissue [28,31]. Therefore, the development of an implant surface that
possesses both osteogenic abilities and antibacterial activity is our ultimate long-term objective [32].
To develop a bioactive surface, many studies have applied growth factors to improve the osteogenic
abilities [33,34] and either antibiotics [15] or inorganic nanoparticles [23] to impart the implant surface
with antibacterial properties. Despite the excellent results reported from these studies, there are clearly
also challenges [35]. Even if a growth factor possesses excellent osteogenic abilities, high cost and
side effects have often been reported [36], whereas inorganic nanoparticles that are effective against
antibiotic-resistant bacteria need verification of their long-term cytotoxicity as they are not degraded
in vivo [23,37]. Additionally, the dipping method of antibiotic polymer coatings for long-term drug
release [20] has been known for the difficulty of forming a uniform coating layer and inability to
conserve the surface structure of the substrate.
Hence, to overcome these problems, this study aimed to apply and verify the ESD method for nontoxic
antibacterial activity by forming a compact TC nanoparticle pattern while preserving the osteogenic ability
of TNTs. The ESD method has been applied in various biomedical areas, including implant coating [38],
scaffold production [39] and biosensors [40]. By adjusting conditions such as the voltage, the distance
between the nozzle and the substrate, the applied pressure on the solvent and the duration of spraying,
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ESD can easily be used to form a surface with the preferred layer characteristics, as observed with the test
samples of this study (Figure 1) [26]. In a previous study where the particles created by the ESD method
resulted in an average diameter of 100 nm [41], our method of using a simple centrifuge stage resulted
in PLGA-coated TC particles with an average diameter of 24.36 nm (Figure 2c). Smaller particle sizes
have many advantages for ESD applications, such as the prevention of metal nozzle blockage, which is a
common problem that can occur when using ESD equipment. In addition, because the sprayed droplets in
the ESD method not only attain a mono-disperse distribution but are also charged, they demonstrate the
merit of decreasing the tendency for droplets to aggregate with each other [26]. Thus, particles were evenly
sprayed along the structure of the tube with a diameter of 100 nm, as seen from T2 to T16 in Figure 2d.
However, when the spraying time increased to T30, there was an intensified aggregation of particles
that resulted in the formation of a layer-like structure, which completely closed the tubular structures.
The thickness of the antibacterial complex layer is expected to determine the bactericidal effectiveness
and toxicity to the cell [42]. Additionally, covering the nanotubular structures, which contribute to the
osteogenic properties, may result in a loss of the bioactive features of the surface [12]. Therefore, the rest
of the investigations in this study focused on seeking the critical point at which the antibacterial activity
and osteogenic properties of the nanotubular structures were maintained without causing cytotoxicity.
Following heat treatment, the TNTs had a low contact angle, which indicates that high
surface energy contributes to the blood infiltrating the surface and enhancing osteoblast attachment.
Additionally, the development of the anatase phase, as confirmed by XRD following heat treatment
of the TNTs, is expected to contribute to the favorable osteogenic properties of the Ti surface
(Figure 2a) [11,43,44].
The antibacterial activity of TC nanoparticles on specimens has been demonstrated with different
degrees of bacterial attachment (Figure 3a). Initially, there was an increased number of S. aureus cells
attached to T0 compared to the flat MA surface, as the surface provided a more favorable surface for
the bacteria to attach as the surface area increased [14]. Rapid decreases in the number of living bacteria
were observed from T2 to T8 as the loading and release of TC gradually increased. PI infiltrates bacteria
possessing damaged membranes and stains the nucleic acids red [45]. However, fluorescent red
bacteria were not observed from T8 to T16 because the damaged bacteria on TC were no longer attached
to the substrate but instead were washed away during the staining process. These results were then
confirmed by the results shown in Figure 3b, where CFU counts were used to monitor the residual
bacterial growth. There were statistically significant decreases in the number of bacteria in T2 and T4,
and bacterial colonization was suppressed from T8 onward.
Despite the positive antibacterial effects of TC shown above, release of TC nanoparticles from
the biomaterial needs to be controlled because they can induce cytotoxicity at overdose levels [42].
The cytotoxicity of each test group was confirmed through the assessment of cell viability using the
LIVE/DEAD assay (Figure 4). The results showed that each cell had a dramatic radial spread in T0
compared to that in MA. The same tendency has been observed from T0 to T8, therefore it seems
to be an effect of the TNT structure [11–13]. Additionally, there was no significant difference in the
number of attached cells, but we found that the cells had already started to transform from T16 and that
dead cells began appearing, as confirmed through CLSM (white arrows). The number of undamaged
cells decreased in T30, and dead cells that were completely round and destroyed by the toxicity of
TC were observed in T60. The ultimate objective of processing the implant surface was to induce
osseointegration [1], therefore we selected 1 group from the test group, T8, which was shown to
maintain the TNT structure without being covered by the TC layer and to impede colonization of
bacteria without causing cytotoxicity to host cells. This group was compared with MA and T0 to
investigate the maintenance of cell attachment and the osteogenic differentiation potency of the TNTs
even after ESD spraying with TC. The results showed that the morphology of cell attachment on T8 was
similar to that on T0 because the topographical cue had been preserved (Figure 5). The TNT structure
contains an empty space in the middle that gives a long distance between the parts that the cells can
attach to, which manifests as an elongation of actin filaments and the cytoskeleton. Although some
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particles that have been sprayed at the edge of the tube exist in a random nanonodule shape (Figure 2c),
there was no significant effect on focal adhesion formation [46–48].
Finally, the ability of TNTs to induce osteogenic differentiation without any chemical factors
was investigated. The RT-PCR results showed that the gene expression of the protein osteogenic
markers OCN and OPN was upregulated and induced differentiation into osteoblasts in both T0 and
T8 compared with the non-TNT surface of the MA group. The high number of fluorescent signals in
OCN and OPN present in T0 and T8 also confirmed that osteogenic signaling was initiated due to the
applied tension to cells through stretching by the TNT surface structure [13]. Furthermore, the results
of ARS staining showed that there was no significant difference in nodule formation and extracellular
matrix mineralization between T0 and T8 (Figure 7). These results clearly suggest that TC particles
sprayed on the T8 surface using the ESD method do not hinder osteoblast differentiation compared
with unsprayed TNT surfaces.
This study showed that a TC-sprayed surface such as T8 formed using ESD demonstrated
antibacterial activity and osteogenic abilities. The ESD method can provide antibacterial activity on the
surface without causing cytotoxicity, while the properties of the TNT structure were preserved from
such an antibacterial coating in terms of the stimulation of OCN and OPN signaling, thus inducing
osteogenic differentiation. However, there is limited prevention of secondary infections after the
complete fixation of implants because only a minimal quantity of TC has been sprayed to preserve
the TNT surface structure. In addition, the wear resistance of the surface during implantation is one
of the tasks to be overcome. Nonetheless, we can expect antibacterial effects against the invasion of
foreign bacteria while the osteogenic ability is maintained during the early critical period, which is
when the cells attach onto the surface and differentiate. Our approach also has the potential to be used
to complexly apply various other ingredients on top of nanotubes using a similar process, which is a
topic of further research.
5. Conclusions
To improve the antibacterial and osteogenic activity of the TNT surface, TC particles were
deposited using the ESD method. Our results showed that the distribution along the tube structures
and release of TC nanoparticles can be controlled by the spraying time. The T8 group showed significant
antimicrobial activity without cytotoxicity. Moreover, the deposition of TC in the T8 group maintained
the osteogenic activity of the TNTs, as demonstrated by the morphology of cells but also by inducing
osteogenic effects of osteoblasts as good as those observed in the T0 group. These results show that,
despite some limitations, TNTs coated with TC nanoparticles using the ESD method have osteogenic
and antibacterial activity, which may be able to reduce the failure rate of implant surgery.
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